Cholesterol drug tested as potential new weapon against cervical cancer
NCT ID NCT06191133
Summary
This early-stage study is testing whether fenofibrate, a common cholesterol medication, can help treat HPV-positive cervical cancer and high-grade precancerous changes. Researchers are giving the drug for a short period before planned surgery to see if it can restore the function of a key tumor-fighting protein (p53) and change how the tumor cells use energy. The study will analyze tissue samples from 24 participants to understand the drug's effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL INTRAEPITHELIAL NEOPLASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
RECRUITINGCleveland, Ohio, 44106, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.